219 related articles for article (PubMed ID: 29091743)
1. Movement Disorders in Children and Adolescents Receiving Antipsychotic Pharmacotherapy: A Population-Based Study.
Biscontri RG; Jha S; Collins DM; Bugden S; Katz LY; Alessi-Severini S
J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):892-896. PubMed ID: 29091743
[TBL] [Abstract][Full Text] [Related]
2. Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study.
Vasilyeva I; Biscontri RG; Enns MW; Metge CJ; Alessi-Severini S
PLoS One; 2013; 8(5):e64217. PubMed ID: 23696870
[TBL] [Abstract][Full Text] [Related]
3. Post authorization safety study comparing quetiapine to risperidone and olanzapine.
Heintjes EM; Overbeek JA; Penning-van Beest FJ; Brobert G; Herings RM
Hum Psychopharmacol; 2016 Jul; 31(4):304-12. PubMed ID: 27297785
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.
Chen W; Cepoiu-Martin M; Stang A; Duncan D; Symonds C; Cooke L; Pringsheim T
Clin Drug Investig; 2018 May; 38(5):449-455. PubMed ID: 29453686
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study.
Chyou TY; Nishtala R; Nishtala PS
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):692-700. PubMed ID: 32301237
[TBL] [Abstract][Full Text] [Related]
7. Risk of Mortality Among Patients Treated With Antipsychotic Medications: A Nationwide Population-Based Study in Taiwan.
Wang LJ; Lee SY; Yuan SS; Yang KC; Yang CJ; Lee TL; Shyu YC
J Clin Psychopharmacol; 2016 Feb; 36(1):9-17. PubMed ID: 26658260
[TBL] [Abstract][Full Text] [Related]
8. Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
Garcia-Amador M; Merchán-Naranjo J; Tapia C; Moreno C; Castro-Fornieles J; Baeza I; de la Serna E; Alda JA; Muñoz D; Andrés Nestares P; Cantarero CM; Arango C
J Clin Psychopharmacol; 2015 Dec; 35(6):686-93. PubMed ID: 26505569
[TBL] [Abstract][Full Text] [Related]
9. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Layton D; Harris S; Wilton LV; Shakir SA
J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
[TBL] [Abstract][Full Text] [Related]
10. Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database.
Osborn DP; Petersen I; Beckley N; Walters K; Nazareth I; Hayes J
J Psychopharmacol; 2018 Oct; 32(10):1098-1103. PubMed ID: 29938561
[TBL] [Abstract][Full Text] [Related]
11. Comparative risk of oral ulcerations among antipsychotics users - population-based retrospective cohort study.
Lai EC; Hsieh CY; Wong MB; Lin SJ; Yang YK; Kao Yang YH; Setoguchi S
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):123-32. PubMed ID: 26549190
[TBL] [Abstract][Full Text] [Related]
12. Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.
Chatterjee S; Chen H; Johnson ML; Aparasu RR
Am J Geriatr Pharmacother; 2012 Apr; 10(2):83-94. PubMed ID: 22306198
[TBL] [Abstract][Full Text] [Related]
13. Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.
Alda JA; Muñoz-Samons D; Tor J; Merchán-Naranjo J; Tapia-Casellas C; Baeza I; Calvo-Escalona R; Castro-Fornieles J; Martínez-Cantarero C; Andrés-Nestares P; Fernández-Avilés F; Arango C
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):449-57. PubMed ID: 26779966
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic use in children and adolescents after initiation of antipsychotic therapy.
Hong IS; Bishop JR
Ann Pharmacother; 2010; 44(7-8):1171-80. PubMed ID: 20587746
[TBL] [Abstract][Full Text] [Related]
15. A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone.
Mintzer JE; Mullen JA; Sweitzer DE
Curr Med Res Opin; 2004 Sep; 20(9):1483-91. PubMed ID: 15383198
[TBL] [Abstract][Full Text] [Related]
16. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.
Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A
J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127
[TBL] [Abstract][Full Text] [Related]
17. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M
J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy.
Carnahan RM; Lund BC; Perry PJ; Chrischilles EA
Acta Psychiatr Scand; 2006 Feb; 113(2):135-41. PubMed ID: 16423165
[TBL] [Abstract][Full Text] [Related]
19. Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study.
Chatterjee S; Chen H; Johnson ML; Aparasu RR
Drugs Aging; 2012 Oct; 29(10):807-17. PubMed ID: 23018582
[TBL] [Abstract][Full Text] [Related]
20. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
Ann Pharmacother; 2001 Dec; 35(12):1517-22. PubMed ID: 11793611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
